Beta-Blockers Reduced the Risk of Mortality and Exacerbation in Patients with COPD: A Meta-Analysis of Observational Studies

Effects of Cardiovascular Drugs on Mortality in Severe Chronic Obstructive Pulmonary Disease

(2013) Magnus P. Ekström et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension

(2012) Mihaela S Stefan et al.   THORAX

Effect of   blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study

(2011) P. M. Short et al.   BMJ-British Medical Journal

β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease

(2010) Frans H. Rutten   ARCHIVES OF INTERNAL MEDICINE

The Prognostic Significance of Heart Rate for Cardiovascular Disease and Hypertension

(2010) Trygve B. Tjugen et al.   CURRENT HYPERTENSION REPORTS

Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)

(2009) Nathaniel M. Hawkins et al.   EUROPEAN JOURNAL OF HEART FAILURE

Current Use of Beta Blockers in Patients With Reactive Airway Disease Who Are Hospitalized With Acute Coronary Syndromes

(2008) Benjamin A. Olenchock et al.   AMERICAN JOURNAL OF CARDIOLOGY

Impact of Cardioselective β-Blockers on Mortality in Patients with Chronic Obstructive Pulmonary Disease and Atherosclerosis

(2008) Yvette R. B. M. van Gestel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Concomitant use of  -blockers and  2-agonists

(2008) Y. Ling et al.   EUROPEAN RESPIRATORY JOURNAL

Chronic Exposure to Beta-Blockers Attenuates Inflammation and Mucin Content in a Murine Asthma Model

(2007) Long P. Nguyen et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

The safety and effects of the beta-blocker, nadolol, in mild asthma: An open-label pilot study

(2007) Nicola A. Hanania et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Changes in β2-adrenoceptor and other signaling proteins produced by chronic administration of ‘β-blockers’ in a murine asthma model

(2007) Rui Lin et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS

Use of   blockers and the risk of death in hospitalised patients with acute exacerbations of COPD

(2007) M T Dransfield et al.   THORAX